BMRN - Biomarin Pharmaceutical Inc. - Registered Shares
IEX Last Trade
91.17
-0.200 -0.219%
Share volume: 1,369,401
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$91.37
-0.20
-0.22%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-10-28 | 2023-02-27 | 2023-04-28 | 2023-08-02 | 2023-11-02 | 2024-02-26 | 2024-04-26 | |
| Total revenue | 533.798 M | 505.344 M | 537.538 M | 596.415 M | 595.275 M | 581.329 M | 646.207 M | 648.833 M | |
| Cost of revenue | 123.126 M | 116.288 M | 127.290 M | 126.549 M | 128.082 M | 124.745 M | 135.478 M | 125.180 M | |
| Gross profit | 410.672 M | 389.056 M | 410.248 M | 469.866 M | 467.193 M | 456.584 M | 510.729 M | 523.653 M | |
| -5.26% | 5.45% | 14.53% | -0.57% | -2.27% | 11.86% | 2.53% | |||
| Operating expenses | 355.025 M | 374.645 M | 418.490 M | 394.849 M | 392.699 M | 415.242 M | 481.274 M | 430.893 M | |
| Selling general and admin | 196.835 M | 216.816 M | 245.739 M | 223.003 M | 215.336 M | 223.928 M | 275.024 M | 225.906 M | |
| Research and development | 158.190 M | 157.829 M | 172.751 M | 171.846 M | 177.363 M | 191.314 M | 206.250 M | 204.987 M | |
| Total expenses | 494.646 M | 507.761 M | 562.038 M | 537.068 M | 536.405 M | 555.668 M | 631.988 M | 570.371 M | |
| 2.65% | 10.69% | -4.44% | -0.12% | 3.59% | 13.73% | -9.75% | |||
| Operating income | 39.152 M | -2.417 M | -24.500 M | 59.347 M | 58.870 M | 25.661 M | 14.219 M | 78.462 M | |
| Ebit | 39.152 M | -2.417 M | -24.500 M | 59.347 M | 58.870 M | 25.661 M | 14.219 M | 78.462 M | |
| Pretax income | 34.851 M | -1.904 M | -17.558 M | 56.757 M | 70.810 M | 41.669 M | 19.327 M | 105.547 M | |
| -105.46% | 822.16% | -423.25% | 24.76% | -41.15% | -53.62% | 446.11% | |||
| Income tax | 7.187 M | 4.748 M | -17.309 M | 5.905 M | 14.770 M | 1.291 M | -1.048 M | 16.885 M | |
| Net income basic | 27.664 M | -6.652 M | -249.000 K | 50.852 M | 56.040 M | 40.378 M | 20.375 M | 88.662 M | |
| -124.05% | 96.26% | 20,522.49% | 10.20% | -27.95% | -49.54% | 335.15% | |||
| Net income | 27.664 M | -6.652 M | -249.000 K | 50.852 M | 56.040 M | 40.378 M | 20.375 M | 88.662 M | |
| -124.05% | 96.26% | 20,522.49% | 10.20% | -27.95% | -49.54% | 335.15% |